Ratings by UBS (Natalia Winkler)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/12/2026 | CEVA Inc. | CEVA | Maintain | Buy (Buy) |
|
Details | ||
| 4/21/2026 | Astera Labs | ALAB | New Coverage | Neutral (N/A) |
174.05 (373.40) |
114.54% | Details | |
| 2/25/2026 | CEVA Inc. | CEVA | New Coverage | Buy (N/A) |
18.76 (42.97) |
129.05% | Details | |
| 2/25/2026 | CEVA Inc. | CEVA | New Coverage | Buy (N/A) |
18.76 (18.76) |
0% | Details |
